Cancer treatment reviews
Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges.
Zoltán Spiró, Amin El-Heliebi, Maximilian J Mair, Thomas R Pieber, Barbara Prietl, Sabine Spiegl-Kreinecker, Stefanie Stanzer, Adelheid Wöhrer, Matthias Preusser, Anna Sophie Berghoff
Published: 202510.1016/j.ctrv.2025.103072
Abstract
The advent of mutation-informed targeted therapies has transformed medical oncology, delivering durable responses in several cancer types. However, this success has not been universal. Tumors such as glioblastoma have largely remained unresponsive to…
Preview only. Read the full abstract at the source